Impact of heat treatment on size, structure, and bioactivity of elemental selenium nanoparticles

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 815-825

  Zhang, Jinsong ^a   Taylor, Ethan W ^b   Wan, Xiaochun ^a   Peng, Dungeng ^c  

^a ANHUI AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioactivity; Heat treatment; Nanoparticle; Selenium

Indexed keywords

GLUTATHIONE TRANSFERASE; NANOPARTICLE; NANOROD; SELENIUM NANOPARTICLE; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG; SELENIUM;

ANIMAL EXPERIMENT; ARTICLE; BIOACCUMULATION; BIOAVAILABILITY; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; HEAT TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR EVOLUTION; MOUSE; NANOANALYSIS; NONHUMAN; PARTICLE SIZE; STRUCTURE ANALYSIS; TEMPERATURE SENSITIVITY; THERMOSTABILITY; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BLOOD; CHEMISTRY; DRUG STABILITY; ENZYMOLOGY; HEAT; LIVER; METABOLISM;

MUS;

ANIMALS; BIOLOGICAL AVAILABILITY; DRUG STABILITY; GLUTATHIONE TRANSFERASE; HOT TEMPERATURE; LIVER; MALE; MICE; NANOPARTICLES; PARTICLE SIZE; SELENIUM;

EID: 84862331416     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S28538     Document Type: Article

References (48)

1. Steinbrenner H, Sies H. Protection against reactive oxygen species by selenoproteins. Biochim Biophys Acta. 2009;1790:1478-1485.
2. Brigelius-Flohé R. Tissue-specific functions of individual glutathione peroxidases. Free Radic Biol Med. 1999;27:951-965.
3. Arnér ES. Focus on mammalian thioredoxin reductases-important selenoproteins with versatile functions. Biochim Biophys Acta. 2009; 1790:495-526.
4. Méplan C, Hughes DJ, Pardini B, et al. Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis. 2010;31: 1074-1079.
5. Peters U, Chatterjee N, Hayes RB, et al. Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2008;17:1144-1154.
6. Diwadkar-Navsariwala V, Prins GS, Swanson SM, et al. Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc Natl Acad Sci U S A. 2006;103:8179-8184.
7. Irons R, Carlson BA, Hatfield DL, Davis CD. Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression. J Nutr. 2006;136: 1311-1317.
8. Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc. 2005;64:527-542.
9. El-Bayoumy K. The protective role of selenium on genetic damage and on cancer. Mutat Res. 2001;475:123-139.
10. Kowalska E, Narod SA, Huzarski T, et al. Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation. Cancer Epidemiol Biomarkers Prev. 2005;14: 1302-1306.
11. Xiao H, Parkin KL. Induction of phase II enzyme activity by various selenium compounds. Nutr Cancer. 2006;55:210-223.
12. El-Sayed WM, Aboul-Fadl T, Lamb JG, Roberts JC, Franklin MR. Effect of selenium-containing compounds on hepatic chemoprotective enzymes in mice. Toxicology. 2006;220:179-188.
13. El-Sayed WM, Aboul-Fadl T, Roberts JC, Lamb JG, Franklin MR. Murine hepatoma (Hepa1c1c7) cells: a responsive in vitro system for chemoprotective enzyme induction by organoselenium compounds. Toxicol In Vitro. 2007;21:157-164.
14. 't Hoen PA, Rooseboom M, Bijsterbosch MK, van Berkel TJ, Vermeulen NP, Commandeur JN. Induction of glutathione-S-transferase mRNA levels by chemopreventive selenocysteine Se-conjugates. Biochem Pharmacol. 2002;63:1843-1849.
15. Prokopczyk B, Rosa JG, Desai D, et al. Chemoprevention of lung tumorigenesis induced by a mixture of benzo(a)pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Cancer Lett. 2000;161:35-46.
16. Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr. 1998;128:1845-1854.
17. Whanger PD. Selenium and its relationship to cancer: an update. Br J Nutr. 2004;91:11-28.
18. Combs GF Jr, Garbisu C, Yee BC, et al. Bioavailability of selenium accumulated by selenite-reducing bacteria. Biol Trace Elem Res. 1996;52:209-225.
19. Ganther HE. Selenotrisulfides. Formation by the reaction of thiols with selenious acid. Biochemistry. 1968;7:2898-2905.
20. Zhang JS, Gao XY, Zhang LD, Bao YP. Biological effects of a nano red elemental selenium. Biofactors. 2001;15:27-38.
21. Wang H, Zhang J, Yu H. Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: comparison with selenomethionine in mice. Free Radic Biol Med. 2007;42:1524-1533.
22. Zhang J, Wang X, Xu T. Elemental selenium at nano size (Nano-Se) as a potential chemopreventive agent with reduced risk of selenium toxicity: comparison with se-methylselenocysteine in mice. Toxicol Sci. 2008;101:22-31.
23. Zhang J, Wang H, Yan X, Zhang L. Comparison of short-term toxicity between Nano-Se and selenite in mice. Life Sci. 2005;76:1099-1109.
24. Jia X, Li N, Chen J. A subchronic toxicity study of elemental Nano-Se in Sprague-Dawley rats. Life Sci. 2005;76:1989-2003.
25. Zhang J, Wang H, Peng D, Taylor EW. Further insight into the impact of sodium selenite on selenoenzymes: high-dose selenite enhances hepatic thioredoxin reductase 1 activity as a consequence of liver injury. Toxicol Lett. 2008;176:223-229.
26. Kong L, Yuan Q, Zhu H, et al. The suppression of prostate LNCaP cancer cells growth by Selenium nanoparticles through Akt/Mdm2/ AR controlled apoptosis. Biomaterials. 2011;32:6515-6522.
27. Tran PA, Webster TJ. Nanotechnologies for cancer diagnostics and treatment. In: Dixon CJ, Curtines OW, editors. Nanotechnology: Nanofabrication, Patterning, and Self Assembly. New York, NY: Nova Science Publishers; 2011.
28. Tran PA, Webster TJ. Selenium nanoparticles inhibit Staphylococcus aureus growth. Int J Nanomedicine. 2011;6:1553-1558.
29. Zhang J, Spallholz J. Toxicity of selenium compounds and nano-selenium particles. In: Casciano D, Sahu SC, editors. Handbook of Systems Toxicology. West Sussex, UK: John Wiley and Sons; 2011.
30. Zhang J. Biological properties of red elemental selenium at nano size (Nano-Se) in vitro and in vivo. In: Sahu SC, Casciano D, editors. Nanotoxicity: From In Vivo and In Vitro Model To Health Risks. West Sussex, UK: John Wiley and Sons; 2009.
31. Kara A, Rahman TS. Vibrational dynamics and thermodynamics of surfaces and nanostructures. Surf Sci Rep. 2005;56:159-187.
32. Maye MM, Zheng W, Leibowitz FL, Ly NK, Zhong CJ. Heating-induced evolution of thiolate-encapsulated gold nanoparticles: A strategy for size and shape manipulations. Langmuir. 2000;16: 490-497.
33. Maye MM, Zhong CJ. Manipulating core-shell reactivities for processing nanoparticle sizes and shapes. J Mater Chem. 2000;10:1895-1901.
34. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
35. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;179:588-590.
36. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249:7130-7139.
37. Holmgren A, Björnstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol. 1995;252:199-208.
38. Ganther H, Ip C. Thioredoxin reductase activity in rat liver is not affected by supranutritional levels of monomethylated selenium in vivo and is inhibited only by high levels of selenium in vitro. J Nutr. 2001;131:301-304.
39. Olson OE, Palmer IS, Cary EE. Modif ication of the off icial fluorometric method for selenium in plants. J Assoc Off Anal Chem. 1975;58:117-121.
40. Peng D, Zhang J, Liu Q, Taylor EW. Size effect of elemental selenium nanoparticles (Nano-Se) at supranutritional levels on selenium accumulation and glutathione S-transferase activity. J Inorg Biochem. 2007;101:1457-1463.
41. Oremland RS, Herbel MJ, Blum JS, et al. Structural and spectral features of selenium nanospheres produced by Se-respiring bacteria. Appl Environ Microbiol. 2004;70:52-60.
42. Mishra RR, Prajapati S, Das J, Dangar TK, Das N, Thatoi H. Reduction of selenite to red elemental selenium by moderately halotolerant Bacillus megaterium strains isolated from Bhitarkanika mangrove soil and characterization of reduced product. Chemosphere. 2011;84:1231-1237.
43. Debieux CM, Dridge EJ, Mueller CM, et al. A bacterial process for selenium nanosphere assembly. Proc Natl Acad Sci U S A. 2011;108:13480-13485.
44. Mishra B, Hassan PA, Priyadarsini KI, Mohan H. Reactions of biological oxidants with selenourea: formation of redox active nanoselenium. J Phys Chem B. 2005;109:12718-12723.
45. Dobias J, Suvorova EI, Bernier-Latmani R. Role of proteins in controlling selenium nanoparticle size. Nanotechnology. 2011;22:195605.
46. Zhang Y, Wang J, Zhang L. Creation of highly stable selenium nanoparticles capped with hyperbranched polysaccharide in water. Langmuir. 2010;26:17617-17623.
47. Zhang J, Wang H, Bao Y, Zhang L. Nano red elemental selenium has no size effect in the induction of seleno-enzymes in both cultured cells and mice. Life Sci. 2004;75:237-244.
48. Huang B, Zhang J, Hou J, Chen C. Free radical scavenging efficiency of Nano-Se in vitro. Free Radic Biol Med. 2003;35:805-813.